Kevin Chen, CEO of Hyasynth Bio
Kevin is the CEO of Hyasynth Bio and working to build a consistent and scalable supply of cannabinoids (CBD, THC, etc.) for new pharmaceuticals and consumer products, produced by genetically engineered yeast. He is passionate about building the Cannabis industry and also about promoting ethics and accessibility of synthetic biology through his work with the iGEM competition.